|
Pfizer ramps up COVID-19 vaccine production as US suggests a pause on J&J doses Fox BusinessConfidence is key issue with Johnson & Johnson vaccine Yahoo NewsHow long will the COVID-19 vaccines protect us? Good Morning AmericaScientists test the risks and rewards of mixing Covid shots Financial TimesCOVI
|
|
 Johnson & Johnson's corporate bonds trade lower across the board Tuesday, after two leading U.S. health agencies recommended a pause on its one-shot COVID-19 vaccine after six vaccinated women developed blood clotting.
|
|
The company announced positive results from an important COVID-19 clinical study.
|
|
Michigan Republicans fire back after CDC director tells state to shut down: 'not the answer' Fox NewsMichigan vaccine rebuff puts Biden and a top ally in a dicey political spot CNN Michigan will pause use of Johnson & Johnson's COVID-19 vaccine, following CDC guidance MLive.comU.S. making strides in COVID vaccination efforts as Michigan grapples with a surge in cases CBS News
|
|
 First, Krispy Kreme offered free donuts for people who get COVID-19 vaccinations. Next up could be local governments handing out gift cards. Is that OK?
|
|
The U.S. COVID-19 vaccine program was facing a setback Tuesday, when the nation's two leading health agencies recommended a pause in the use of the Johnson & Johnson vaccine to allow their scientists investigate six cases of blood clotting in individuals who had been vaccinated.
|
RELATED ARTICLES | | | | |
|
 Americans have tons of questions about their stimulus checks and 2020 taxes. Here's what you need to know about 2021 COVID-relief payments and more.
|
|
 Novavax Inc. said late Tuesday that Chief Financial Officer Greg Covino is stepping down for personal reasons, but will remain connected to the company as an executive adviser. The biotech also said it promoted Gale E. Smith to chief scientist and Troy Morgan as chief compliance officer. Executive Vice President John J. Trizzino will assume the role of CFO while the company searches for a permanent replacement. Novavax said last week it will expand clinical trials of its COVID-19 vaccine candidate to include children and teens. Earlier this year, the company said it hoped to get an emergency-use authorization from the FDA for its vaccine candidate in May. Shares of Novavax fell 0.9% in the extended session Tuesday after the stock rallied nearly 11% during the regular trading day.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
Federal health officials say the ultra-rare blood clots reported in six people who received Johnson & Johnson's COVID-19 vaccine are similar to blood clots detected in a very small number of people in Europe who were immunized with AstraZeneca's shot.
|
|
Air Canada will now offer refunds for flights affected by COVID-19 since February 1, 2020 as part of government financial aid deal.
|
|
Green energy supplier takes top spot and London remains the city with the most high-growth businesses
|
|
